Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maja A Sommerfelt

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Expert Opinion on Therapeutic Patents|May 22, 2009
Circular CCR5 peptide conjugates and uses thereof (WO2008074895)Maja A Sommerfelt
Expert Opinion on Biological Therapy|May 15, 2008
Prospects for HIV-1 therapeutic immunisation and vaccination: the potential contribution of peptide immunogensMaja A Sommerfelt, Birger Sørensen
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|February 14, 2003
The influence of CD4 and CXCR4 on maedi-visna virus-induced syncytium formationArnt-Ove Hovden, Maja A Sommerfelt
Virology|October 31, 2003
The endogenous langur type D retrovirus PO-1-Lu and its exogenous counterparts in macaque and langur monkeysMaja A Sommerfelt, Nina Harkestad, Eric Hunter
Expert Opinion on Biological Therapy|March 10, 2004
Novel peptide-based HIV-1 immunotherapyMaja A Sommerfelt, Jørgen Nyhus, Birger Sørensen
Journal of Virological Methods|December 12, 2003
A simple semi-rapid HIV-1&2 confirmatory immunoassay using magnetic particlesMaja A Sommerfelt, Irene Ohlsson, Irene Flolid, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|February 21, 2012
Delayed-type hypersensitivity responses to HIV Gag p24 relate to clinical outcome after peptide-based therapeutic immunization for chronic HIV infectionAnne-Marte B Kran, Maja A Sommerfelt, Ingebjørg Baksaas, et al.
AIDS (London, England)|February 14, 2006
Long-term HIV-specific responses and delayed resumption of antiretroviral therapy after peptide immunization targeting dendritic cellsAnne-Marte B Kran, Birger Sørensen, Maja A Sommerfelt, et al.
Vaccine|November 18, 2005
Multiple antigen concentrations in delayed-type hypersensitivity (DTH) and response diversity during and after immunization with a peptide-based HIV-1 immunotherapy candidate (Vacc-4x)Jørgen Nyhus, Anne-Marte Bakken Kran, Maja A Sommerfelt, et al.
AIDS (London, England)|October 12, 2010
Low frequency of amino acid alterations following therapeutic immunization with HIV-1 Gag p24-like peptidesAnne-Marte B Kran, Tom Oystein Jonassen, Maja A Sommerfelt, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Expert Opinion on Therapeutic Patents|May 22, 2009
Circular CCR5 peptide conjugates and uses thereof (WO2008074895)Maja A Sommerfelt
Expert Opinion on Biological Therapy|May 15, 2008
Prospects for HIV-1 therapeutic immunisation and vaccination: the potential contribution of peptide immunogensMaja A Sommerfelt, Birger Sørensen
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|February 14, 2003
The influence of CD4 and CXCR4 on maedi-visna virus-induced syncytium formationArnt-Ove Hovden, Maja A Sommerfelt
Virology|October 31, 2003
The endogenous langur type D retrovirus PO-1-Lu and its exogenous counterparts in macaque and langur monkeysMaja A Sommerfelt, Nina Harkestad, Eric Hunter
Expert Opinion on Biological Therapy|March 10, 2004
Novel peptide-based HIV-1 immunotherapyMaja A Sommerfelt, Jørgen Nyhus, Birger Sørensen
Journal of Virological Methods|December 12, 2003
A simple semi-rapid HIV-1&2 confirmatory immunoassay using magnetic particlesMaja A Sommerfelt, Irene Ohlsson, Irene Flolid, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|February 21, 2012
Delayed-type hypersensitivity responses to HIV Gag p24 relate to clinical outcome after peptide-based therapeutic immunization for chronic HIV infectionAnne-Marte B Kran, Maja A Sommerfelt, Ingebjørg Baksaas, et al.
AIDS (London, England)|February 14, 2006
Long-term HIV-specific responses and delayed resumption of antiretroviral therapy after peptide immunization targeting dendritic cellsAnne-Marte B Kran, Birger Sørensen, Maja A Sommerfelt, et al.
Vaccine|November 18, 2005
Multiple antigen concentrations in delayed-type hypersensitivity (DTH) and response diversity during and after immunization with a peptide-based HIV-1 immunotherapy candidate (Vacc-4x)Jørgen Nyhus, Anne-Marte Bakken Kran, Maja A Sommerfelt, et al.
AIDS (London, England)|October 12, 2010
Low frequency of amino acid alterations following therapeutic immunization with HIV-1 Gag p24-like peptidesAnne-Marte B Kran, Tom Oystein Jonassen, Maja A Sommerfelt, et al.
Pageof 3